Most (over 85%) of the insulin pumps are currently available in the market / commercialized, demonstrating the maturity of industry and significant demand of consumers. It is worth mentioning that maximum number of the insulin pumps were launched post-2018; examples of recently launched pumps include (in alphabetical order) iLet ACE Pump (Beta Bionics, 2023), Kaleido (ViCentra, 2023) and Tandem Mobi System (Tandem Diabetes Care, 2024).

The insulin pump market size is projected to grow from $ 5.8 billion in 2024 to $ 13.6 billion by 2035, representing a CAGR of 8% during the forecast period till 2035.

Additionally, patch pumps dominate the insulin pumps domain; these pumps directly adhere to the patients’ skin (due to the presence of an adhesive backing) and deliver insulin into the body via a small tube (inserted into the skin). Some advantages of the patch pumps include discreetness (enables easy concealment under clothes), convenience (eliminating the requirement of additional infusion set components) and improved mobility (due to the absence of external tubing).

Around 80% of the insulin pumps are automated / smart pumps; these pumps allow automatic adjustment of insulin doses (based on real-time glucose information), integration with continuous glucose monitors (to offer precise insulin management) and compatibility with diabetes management software (to enable health data sharing with caregivers). In addition, smart pumps offer smartphone connectivity in order to effectively track the medication activity of patients; these pumps are beneficial for children or elderly users. Notably, over 10% of the insulin pumps are suitable for the delivery of insulin in patients suffering from Type 1 and Type 2 diabetes.

The Insulin Pumps Market Is Anticipated to Grow at a Steady Pace, Till 2035

The different driving factors for the insulin pumps market include the growing prevalence of chronic diseases (requiring real-time monitoring), shift towards decentralized trials (eliminating need for frequent in-person visits by the patient) and increasing adoption of smart digital devices. Our estimates suggest that, presently, in terms of type of pump, majority share of the insulin pumps market is captured by patch pumps; this can be attributed to the fact that they can be conveniently operated wirelessly by a separate device to monitor blood sugar levels continuously throughout the day and allow automatic delivery of insulin after meals.

In 2024, most of the revenue generated in insulin pumps domain is likely to be driven by automated / smart pumps, followed by revenues generated by manual pumps. It is worth mentioning that, in 2035, rechargeable batteries are likely to dominate the insulin pumps market.

Further, currently, the maximum revenue generated in this domain is likely to be driven by insulin pumps targeting Type 1 diabetes and this trend (in terms of market size) is unlikely to change in the future as well. Notably, the insulin pumps market is anticipated to grow at a higher pace, having a CAGR of 8%, during the forecast period. Moreover, in 2024, retail pharmacies capture around 50% share of the overall market, followed by the market share captured by online pharmacies (23%).

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/insulin-pump-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/